Determination of a novel gamma-secretase inhibitor in human plasma and cerebrospinal fluid using automated 96 well solid phase extraction and liquid chromatography/tandem mass spectrometry

スポンサーリンク

概要

• 論文の詳細を見る
• 2008-02-15

著者

• Woolf Eric

  Merck Research Laboratories

• Matthews Catherine

  Merck Research Laboratories Department Of Drug Metabolism

• Woolf Eric

  Dep. Of Drug Metabolism And Pharmacokinetics Merck Res. Laboratories Merck & Co. Inc. Wp758-300

関連論文

• Concerns in the development of an assay for determination of a highly conjugated adsorption-prone compound in human urine
• Determination of the HIV integrase inhibitor, MK-0518 (raltegravir), in human plasma using 96-well liquid-liquid extraction and HPLC-MS/MS
• Elimination of diastereomer interference to determine Telcagepant (MK-0974) in human plasma using on-line turbulent-flow technology and off-line solid-phase extraction coupled with liquid chromatography/tandem mass spectrometry
• Determination of an investigational HIV integrase inhibitor in human plasma using high performance liquid chromatography with tandem mass spectrometric detection
• Determination of risedronate in human urine by column-switching ion-pair high-performance liquid chromatography with ultraviolet detection
• High-throughput, semi-automated determination of a cyclooxygenase II inhibitor in human plasma and urine using solid-phase extraction in the 96-well format and high-performance liquid chromatography with post-column photochemical derivatization-fluorescen
• Determination of a novel gamma-secretase inhibitor in human plasma and cerebrospinal fluid using automated 96 well solid phase extraction and liquid chromatography/tandem mass spectrometry

スポンサーリンク